Eisai will request reconsideration of preliminary determination for lecanemab in Australia By Investing.com
STOCKHOLM, Oct. 16, 2024 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA…
By
Tycoon Herald
7 Min Read